Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa

Background: Despite a high incidence of sickle cell anemia, hydroxyurea (HU) treatment is rarely used in the DR Congo. This study aims to assess the efficacy of HU, the incidence of side effects that may limit its use in adults and to determine the dose needed for clinical improvement in patients. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabuyi, Paul Lumbala, Mbayabo, Gloire, Ngole, Mamy, Zola, Aimé Lumaka, Race, Valerie, Matthijs, Gert, Van Geet, Chris, Tshilobo, Prosper Lukusa, Devriendt, Koenraad, Mikobi, Tite Minga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Sickle Cell, Thrombosis, and Classical Haematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435708/
https://www.ncbi.nlm.nih.gov/pubmed/37601858
http://dx.doi.org/10.1002/jha2.735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435708/
https://www.ncbi.nlm.nih.gov/pubmed/37601858
http://dx.doi.org/10.1002/jha2.735

Ejemplares similares